YH 124 Pill - beige green capsule/oblong, 14mm
Pill with imprint YH 124 is Beige / Green, Capsule/Oblong and has been identified as Memantine Hydrochloride Extended-Release 14 mg. It is supplied by Slate Run Pharmaceuticals, LLC.
Memantine is used in the treatment of Alzheimer's Disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 14 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for YH 124
Memantine Hydrochloride Extended-Release
- Imprint
- YH 124
- Strength
- 14 mg
- Color
- Beige / Green
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Slate Run Pharmaceuticals, LLC
- Manufacturer
- Yichang Humanwell
- National Drug Code (NDC)
- 70436-0055
- Inactive Ingredients
-
ammonia,
ethylcellulose,
ferric oxide yellow,
ferrosoferric oxide,
FD&C Blue No. 1,
FD&C Yellow No. 6,
gelatin,
hydroxyethyl cellulose,
hypromelloses,
medium-chain triglycerides,
oleic acid,
polyethylene glycol 400,
polyethylene glycol 8000,
potassium hydroxide,
shellac,
talc,
titanium dioxide
Note: Inactive ingredients may vary.
More about memantine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (90)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
- Memantine drug information
- Memantine (Advanced Reading)
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
Other brands
Professional resources
- Memantine monograph
- Memantine (FDA)
- Memantine ER Tablets (FDA)
- Memantine ER capsules (FDA)
- Memantine Oral Solution (FDA)
- Memantine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
